Punctate inner choroidopathy

Survey of Ophthalmology

Volumn 56, Issue 1, 2011, Pages 36-53

  Amer, Radgonde ^a,b   Lois, Noemi ^a  

^a NHS GRAMPIAN   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acute posterior multifocal placoid pigment epitheliopathy; Acute zonal occult outer retinopathy; Anti angiogenic factors; Birdshot retinochoroidopathy; Choroidal neovascular membrane; Diffuse subretinal fibrosis syndrome; Multifocal choroiditis and panuveitis; Multiple evanescent white dot syndrome; Photodymanic therapy; Presumed ocular histoplasmosis syndrome; Punctate inner choroidopathy; Serpiginous choroiditis; White dot syndromes

Indexed keywords

BETA1A INTERFERON; BEVACIZUMAB; CYCLOSPORIN; FLUOCINOLONE ACETONIDE; PREDNISOLONE; RAPAMYCIN; THALIDOMIDE; TRIAMCINOLONE;

ACUTE ZONAL OCCULT OUTER RETINOPATHY; AUTOIMMUNE DISEASE; BLURRED VISION; CHORIORETINOPATHY; CHOROID DISEASE; CHOROIDITIS; CLINICAL FEATURE; DEVICE REMOVAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ELECTRORETINOGRAPHY; EYE INFLAMMATION; GLAUCOMA; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE PORT SYSTEM; INCIDENCE; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; MULTIFOCAL CHOROIDITIS; MULTIPLE EVANESCENT WHITE DOT SYNDROME; MYOPIA; OCULAR HISTOPLASMOSIS; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTOPHOBIA; PHOTOPSIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PUNCTATE INNER CHOROIDOPATHY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA PIGMENT EPITHELIOPATHY; RETINA SURGERY; RETINOPATHY; REVIEW; SCOTOMA; SERPIGINOUS CHOROIDOPATHY; SLIT LAMP; SLOW RELEASE FORMULATION; STEROID THERAPY; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD; VITILIGINOUS CHORIORETINITIS; VITREOUS FLOATERS;

CHORIORETINITIS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS;

EID: 78650226306     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2010.03.009     Document Type: Review

References (131)

1. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial inkling lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-60.
2. Aaberg T.M. Multiple evanescent white dot syndrome. Arch Ophthalmol 1988, 106:1162-1163.
3. Akman A., Kadayifçilar S., Aydin P. Indocyanine green angiographic findings in a case of punctate inner choroidopathy. Eur J Ophthalmol 1998, 8:191-194.
4. Akpek E.K., Baltatzis S., Yang J., et al. Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm 2001, 9:153-167.
5. Akpek E.K., Jabs D.A., Tessler H.H., et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 2002, 109:1506-1513.
6. Anderson K., Patel K.R., Webb L., et al. Acute posterior multifocal placoid pigment epitheliopathy associated with pulmonary tuberculosis. Br J Ophthalmol 1996, 80:186.
7. Baarsma G.S., Priem H.A., Kijlstra A. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res 1990, 9(Suppl):63-68.
8. Barile G.R., Reppucci V.S., Schiff W.M., et al. Circumpapillary chorioretinopathy in multiple evanescent white dot syndrome. Retina 1997, 17:75-77.
9. Becker K.G. The common genetic hypothesis of autoimmune/inflammatory disease. Curr Opin Allergy Clin Immunol 2001, 1:399-405.
10. Becker K.G., Simon R.M., Bailey-Wilson J.E., et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998, 95:9979-9984.
11. Becker M.D., Wertheim M.S., Smith J.R., et al. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression. Ocul Immunol Inflamm 2005, 13:289-293.
12. Berger A.S., Kaplan H.J. Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmology 1992, 99:969-976.
13. Bodine S.R., Marino J., Camisa T.J., et al. Multifocal choroiditis with evidence of Lyme disease. Ann Ophthalmol 1992, 24:169-173.
14. Boisgerault F., Khalil I., Tieng V., et al. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc Natl Acad Sci USA 1996, 93:3466-3470.
15. Brézin A.P., Massin-Korobelnik P., Boudin M., et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol 1995, 113:297-300.
16. Bridges W.J., Saadeh C., Gerald R. Acute posterior multifocal placoid pigment epitheliopathy in a patient with systemic-onset juvenile rheumatoid arthritis: treatment with cyclosporin A and prednisone. Arthritis Rheum 1995, 38:446-447.
17. Brown J., Folk J.C., Reddy C.V., et al. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996, 103:1100-1105.
18. Chan W.M., Lai T.Y., Liu D.T., et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007, 143:977-983.
19. Chan W.M., Timothy Y.Y., Lau T., et al. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularisation secondary to punctate inner choroidopathy or of idiopathic origin. One-year results of a prospective series. Retina 2008, 28:71-80.
20. Chatterjee S., Gibson J.M. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003, 87:925-927.
21. Chiquet C., Lumbroso L., Denis P., et al. Acute posterior multifocal placoid pigment epitheliopathy associated with Wegener's granulomatosis. Retina 1999, 19:309-313.
22. Cirino A.C., Mathura J.R., Jampol L.M. Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 2006, 26:1091-1092.
23. Ciulla T.A., Piper H.C., Xiao M., et al. Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies. Curr Opin Ophthalmol 2001, 12:442-449.
24. Coco R.M., de Souza C.F., Sanabria M.R. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm 2007, 15:27-29.
25. Comu S., Verstraeten T., Rinkoff J.S., et al. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke 1996, 27:996-1001.
26. Dejneka N.S., Kuroki A.M., Fosnot J., et al. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 2004, 10:964-972.
27. Dhaliwal R.S., Maguire A.M., Flower R.W., et al. Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study. Retina 1993, 13:317-325.
28. Dick D.J., Newman P.K., Richardson J., et al. Acute posterior multifocal placoid pigment epitheliopathy and sarcoidosis. Br J Ophthalmol 1988, 72:74-77.
29. Di Crecchio L., Parodi M.B., Saviano S., et al. Acute posterior multifocal placoid pigment epitheliopathy and ulcerative colitis: a possible association. Acta Ophthalmol Scand 2001, 79:319-321.
30. Dodwell D.G., Jampol L.M., Rosenberg M., et al. Optic nerve involvement associated with the multiple evanescent white-dot syndrome. Ophthalmology 1990, 97:862-868.
31. Dreyer R.F., Gass D.J. Multifocal choroiditis and panuveitis. A syndrome that mimics ocular histoplasmosis. Arch Ophthalmol 1984, 102:1776-1784.
32. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
33. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-858.
34. Fine H.F., Spaide R.F., Ryan E.H., et al. Acute zonal occult outer retinopathy in patients with multiple evanescent white dot syndrome. Arch Ophthalmol 2009, 127:66-70.
35. Flaxel C.J., Owens S.L., Mulholland B., et al. The use of corticosteroids for choroidal neovascularisation in young patients. Eye 1998, 12:266-272.
36. Fong K.C., Thomas D., Amin K., et al. Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. Eye 2007, 22:528-533.
37. Francis P.J., Marinescu A., Fitzke F.W., et al. Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol 2005, 89:70-73.
38. Ganley J.P. Epidemiologic characteristics of presumed ocular histoplasmosis. Acta Ophthalmol 1973, 119:1.
39. Gass J.D. Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases?. Am J Ophthalmol 2003, 135:380-381.
40. Gass JD. Acute zonal occult outer retinopathy: Donders Lecture: The Netherlands Ophthalmological Society. Maastricht, Holland, 19 June 1992. Retina. 2003;23:79-97.
41. Gass J.D.M. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment 1997, CV Mosby, St. Louis, MO, 688-93. 4th ed.
42. Gass J.D.M. Biomicroscopic and histopathologic consideration regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994, 118:285-298.
43. Gass J.D. The acute zonal outer retinopathies. Am J Ophthalmol 2000, 130:655-657.
44. Gass J.D., Agarwal A., Scott I.U. Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol 2002, 134:329-339.
45. Gass J.D. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1968, 80:177-185.
46. Gass J.D. Vitiliginous chorioretinitis. Arch Ophthalmol 1981, 99:1778-1787.
47. Gerstenblith A.T., Thorne J.E., Sobrin L., et al. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 2007, 114:1201-1204.
48. Goldstein D.A., Godfrey D.G., Hall A., et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol 2007, 125:1478-1485.
49. Holder G.E., Robson A.G., Pavesio C., et al. Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol 2005, 89:709-718.
50. Holekamp N.M., Thomas M.A., Pearson A. The safety profile of long-term, high-dose intraocular corticosteroid delivery. Am J Ophthalmol 2005, 139:421-428.
51. Holt W.S., Regan C.D., Trempe C. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol 1976, 81:403-412.
52. Hooper P.L., Kaplan H.J. Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 1991, 98:944-951.
53. Ie D., Glaser B.M., Murphy R.P., et al. Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol 1994, 117:7-12.
54. Ip M., Gorin M.B. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide. Am J Ophthalmol 1996, 122:594-595.
55. Ishibashi T., Miki K., Sorgente N., et al. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in subhuman primate. Arch Ophthalmol 1985, 103:708-711.
56. Jacklin H.N. Acute posterior multifocal placoid pigment epitheliopathy and thyroiditis. Arch Ophthalmol 1977, 95:995-997.
57. Jaffe G.J., Ben-Nun J., Guo H., et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 2000, 107:2024-2033.
58. Jaffe G.J., Martin D., Callanan D., et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 2006, 113:1020-1027. Fluocinolone Acetonide Uveitis Study Group.
59. Jaffe G.J., McCallum R.M., Branchaud B., et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005, 112:1192-1198.
60. Jaffe G.J., Yang C.H., Guo H., et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 2000, 41:3569-3575.
61. Jampol L.M., Becker K.G. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol 2003, 135:376-379.
62. Jampol L.M., Orth D., Daily M.J. Subretinal neovascularisation with geographic (serpiginous) choroiditis. Am J Ophthalmol 1979, 88:683-689.
63. Jampol L.M., Sieving P.A., Pugh D., et al. Multiple evanescent white dot syndrome, I: clinical findings. Arch Ophthalmol 1984, 102:671-674.
64. Jampol L.M., Wiredu A. MEWDS, MFC, PIC, AMN, AIBSE, and AZOOR: one disease or many?. Retina 1995, 15:373-378.
65. Kaiser P.K., Brown D.M., Zhang K., et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007, 144:850-857.
66. Kaplan H.J., Aaberg T.M. Birdshot retinochoroidopathy. Am J Ophthalmol 1980, 90:773-782.
67. Kedhar S.R., Thorne J.E., Wittenberg S., et al. Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina 2007, 27:1174-1179.
68. Kramer M., Miller J.W., Michaud N., et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996, 103:427-438.
69. Kvanta A., Algvere P.V., Berglin L., et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1996, 37:1929-1934.
70. Laatikainen L., Immonen I. Multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol 1988, 226:37-40.
71. Laatikainen L.T., Immonen I.J. Acute posterior multifocal placoid pigment epitheliopathy in connection with acute nephritis. Retina 1988, 8:122-124.
72. Laatikainen L., Erkkila H. Subretinal and disc neovascularisation in serpiginous choroiditis. Br J Ophthalmol 1982, 66:326-331.
73. Laatikainen L., Tarkkanen A. Failure of cyclosporin A in serpiginous choroiditis. J Ocul Ther Surg 1984, 3:280-283.
74. Laatikainen L., Erkkilä H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol 1981, 59:707-718.
75. Le Hoang P., Girard B., Deray G., et al. Cyclosporine in the treatment of birdshot retinochoroidopathy. Transplant Proc 1988, 20(Suppl):128-130.
76. Leslie T., Lois N., Christopoulou D., et al. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 2005, 89:147-150.
77. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
78. Levinson R.D., Gonzales C.R. Birdshot retinochoroidopathy immunopathogenesis, evaluation, and treatment. Ophthalmol Clin North Am 2002, 15:343-350.
79. Levy J., Shneck M., Klemperer I., et al. Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 2005, 40:605-608.
80. Lim J.I., Flaxel C.J., LaBree L. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 2006, 35:198-202.
81. Lowder C.Y., Foster R.E., Gordon S.M., et al. Acute posterior multifocal placoid pigment epitheliopathy after acute group A streptococcal infection. Am J Ophthalmol 1996, 122:115-117.
82. Mansour A.M., Jampol L.M., Packo K.H., et al. Macular serpiginous choroiditis. Retina 1988, 8:125-131.
83. Matsuda S., Gomi F., Oshima Y., et al. Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE 19 cells under oxidative stress. Invest Ophthalmol Vis Sci 2005, 46:1062-1068.
84. Meyer R.J., Jampol L.M. Recurrences and bilaterality in the multiple evanescent white-dot syndrome. Am J Ophthalmol 1986, 101:388-389.
85. Moshfeghi D.M., Kaiser P.K., Grossniklaus H.E., et al. Clinicopathological study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol 2003, 135:343-350.
86. Morgan C.M., Schatz H. Recurrent multifocal choroiditis. Ophthalmology 1986, 93:1138-1143.
87. Nussenblatt R.B., Coleman H., Jirawuthiworavong G., et al. The treatment of multifocal choroiditis associated choroidal neovascularization with sirolimus (rapamycin). Acta Ophthalmol Scand 2007, 85:230-231.
88. Nussenblatt R.B., Mittal K.K., Ryan S., et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982, 94:147-158.
89. Nussenblatt R.B., Palestine A.G. Uveitis: Fundamentals and Clinical Practice 1989, Year Book Medical, Chicago, p 313.
90. Obana A., Kusumi M., Miki T. Indocyanine green angiographic aspects of multiple evanescent white dot syndrome. Retina 1996, 16:97-104.
91. Olsen T.W., Capone A., Sternberg P., et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996, 103:2061-2069.
92. Opremcak E.M. Birdshot retinochoroiditis. Principles and Practice of Ophthalmology: Clinical Practice, Vol. 1 1994, 475-480. WB Saunders, Philadelphia, PA. D.M. Albert, F.A. Jakobiec (Eds.).
93. Park C.H., Raizman M.B. Punctate inner choroidopathy. Diagnosis and Treatment of Uveitis 2002, 806-812. WB Saunders, Philadelphia. C.S. Foster, A.T. Vitale (Eds.).
94. Parmeggiani F., Costagliola C., D'Angelo S., et al. Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy. Oncology 2004, 66:502-509.
95. Pinto Ferreira F., Faria A., Ganhão F. Periarteritis nodosa with initial ocular involvement. J Fr Ophtalmol 1995, 18:788-793.
96. Postelmans L., Pasteels B., Coquelet P., et al. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm 2005, 13:361-366.
97. Prasad A.G., Van Gelder R.N. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol 2005, 16:364-368.
98. Priem H.A., Oosterhuis J.A. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol 1988, 72:646-659.
99. Quillen D.A., Davis J.B., Gottlieb J.L., et al. The white dot syndromes. Am J Ophthalmol 2004, 137:538-550.
100. Reddy C.V., Brown J., Folk J.C., et al. Enlarged blind spots in chorioretinal inflammatory disorders. Ophthalmology 1996, 103:606-617.
101. Rodriguez A., Calonge M., Pedroza-Seres M., et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996, 114:593-599.
102. Rogers A.H., Duker J.S., Nichols N., et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003, 110:1315-1320.
103. Rogers A.H., Martidis A., Greenberg P.B., et al. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002, 134:566-576.
104. Rosen E., Rubowitz A., Ferencz J.R. Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy. Eye (Lond) 2009, 23(6):1479.
105. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1419-1431. MARINA Study Group.
106. Ryan S.J., Maumenee A.E. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol 1972, 74:1066-1074.
107. Ryan S.J., Maumenee A.E. Birdshot retinochoroidopathy. Am J Ophthalmol 1980, 89:31-45.
108. Schatz H., Maumenee A., Patz A. Geographic helicoid peripapillary choroidopathy: clinical presentation and fluorescein angiographic findings. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:747-761.
109. Schmidt-Erfurth U., Schlotzer-Schrehard U., Cursiefen C., et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003, 44:4473-4480.
110. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
111. Shimada H., Yuzawa M., Hirose T., et al. Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy. Jpn J Ophthalmol 2008, 52:282-288.
112. Sim D.A., Sheth H.G., Kaines A., et al. Punctate inner choroidopathy-associated choroidal neovascular membranes during pregnancy. Eye 2008, 22:725-727.
113. Singerman L.J. Discussion of recurrent multifocal choroiditis. Ophthalmology 1986, 93:1143-1147.
114. Slusher M.M., Weaver R.G. Multiple evanescent white dot syndrome. Retina 1988, 8:132-135.
115. Spaide R.F., Freund K.B., Slakter J., et al. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002, 22:545-549.
116. Spaide R.F., Sorenson J., Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003, 110:1517-1525.
117. Taira K., Nakazawa M., Takano Y., Ota T. Acute zonal occult outer retinopathy in the fellow eye 5 years after presentation of punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol 2006, 244(7):880-882.
118. Thomson S.P., Roxburgh S.T. Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus infection. Eye 2003, 17:542-544.
119. Tiffin P.A., Maini R., Roxburgh S.T., et al. Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol 2002, 80:90-91.
120. Volpe N.J., Rizzo J.F., Lessell S. Acute idiopathic blind spot enlargement syndrome: a review of 27 new cases. Arch Ophthalmol 1995, 119:59-63.
121. Vossmerbaeumer U, Spandau UH, V Baltz S, et al. Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Experiment Ophthalmol. 2008;36:292-294.
122. Wachtlin J., Heimann H., Behme T., et al. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 2003, 241:899-906.
123. Watzke R.C., Packer A.J., Folk J.C., et al. Punctate inner choroidopathy. Am J Ophthalmol 1984, 98:572-584.
124. Watzke R.C., Shults W.T. Clinical features and natural history of the acute idiopathic enlarged blind spot syndrome. Ophthalmology 2002, 109:1326-1335.
125. Weiss H., Annesly W.J., Shields J.A. The clinical course of serpiginous choroidopathy. Am J Ophthalmol 1979, 87:133-142.
126. Wolf M.D., Alward W.L., Folk J.C. Long-term visual function in acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1991, 109:800-803.
127. Wu J.S., Lewis H., Fine S.L., et al. Clinicopathologic findings in a patient with serpiginous choroidopathy and treated choroidal neovascularisation. Retina 1989, 9:292-301.
128. Wyhinny G.J., Jackson J.L., Jampol L.M., et al. Subretinal neovascularization following multiple evanescent white-dot syndrome. Arch Ophthalmol 1990, 108:1384-1385.
129. Yang D.S., Hilford D.J., Conrad D. Acute posterior multifocal placoid pigment epitheliopathy after meningococcal C conjugate vaccine. Clin Experiment Ophthalmol 2005, 33:219-221.
130. Yuzawa M., Kawamura A., Matsui M. Indocyanine green video angiographic findings in acute posterior multifocal placoid pigment epitheliopathy. Acta Ophthalmol 1994, 72:128-133.
131. Zacks D.N., Samson C.M., Loewenstein J., et al. Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol 2002, 240:601-607.